38 Interstitial Cystitis Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Interstitial Cystitis Studies in Birmingham

NCT05953090Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to te...

Birmingham, ALNA2,000 participantsStratpharma AG

View Study Details

NCT06578195Recruiting

ASSESS ALL ALS Study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS ge...

Birmingham, AL2,000 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

NCT06289985Recruiting

StrokeNet Thrombectomy Endovascular Platform

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO)....

Birmingham, ALNA1,600 participantsMedical University of South Carolina

View Study Details

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Birmingham, ALPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06087029Recruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic com...

Birmingham, ALNA1,100 participantsDuke University

View Study Details

NCT05219110Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E...

Birmingham, ALNA1,040 participantsUniversity of Calgary

View Study Details

NCT06071377Recruiting

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences ...

Birmingham, AL1,000 participantsNational Alliance for Sickle Cell Centers

View Study Details

NCT07290803Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey...

Birmingham, AL1,000 participantsSanofi

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Birmingham, AL750 participantsBoston Children's Hospital

View Study Details

NCT06973187Recruiting

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

The purpose of this study is to evaluate the efficacy and safety of BGB-16673 alone compared with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or smal...

Birmingham, ALPHASE3500 participantsBeOne Medicines

View Study Details

NCT07281430Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve ce...

Birmingham, ALNA500 participantsNational Cancer Institute (NCI)

View Study Details

NCT01299168Recruiting

Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation

The current standard for biopsy-based diagnoses of dysfunction of kidney transplants is the Banff Classification which represents arbitrary international consensus. Recent data-driven approaches using...

Birmingham, AL500 participantsUniversity of Alberta

View Study Details

NCT06906640Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States....

Birmingham, ALNA420 participantsDuke University

View Study Details

NCT06510075Recruiting

Providing an Optimized and Empowered Pregnancy for You (POPPY) Aim 3: Randomized Controlled Trial

The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The P3OPPY Project is...

Birmingham, ALNA400 participantsUniversity of Alabama at Birmingham

View Study Details

NCT07532603Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris...

Birmingham, ALPHASE2342 participantsPriovant Therapeutics, Inc.

View Study Details

NCT05995964Recruiting

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic dermatitis (AD). AD is a long- lasting itchy red rash,...

Birmingham, ALPHASE2340 participantsPfizer

View Study Details

NCT05702645Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment...

Birmingham, AL330 participantsChildren's Oncology Group

View Study Details

NCT07335497Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) ...

Birmingham, ALPHASE1290 participantsCrescent Biopharma, Inc.

View Study Details

NCT05004051Recruiting

ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA

This is a Prospective Registry study to collect imaging and clinical data both on patients with aortic aneurysm disease undergoing serial monitoring and on patients pre and post-endovascular repair, u...

Birmingham, AL200 participantsViTAA Medical Solutions

View Study Details

NCT06237335Recruiting

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

This is the first-in-human study with RCT2100 and is designed to provide safety and tolerability data for future clinical studies....

Birmingham, ALPHASE2192 participantsReCode Therapeutics

View Study Details

NCT06549348Recruiting

Radiation Free Study

This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizab...

Birmingham, ALNA182 participantsPhilips Clinical & Medical Affairs Global

View Study Details

NCT07091630Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or pl...

Birmingham, ALPHASE3160 participantsargenx

View Study Details

NCT06239116Recruiting

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment...

Birmingham, ALPHASE1150 participantsRhythm Pharmaceuticals, Inc.

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Birmingham, ALPHASE1150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT04433065Recruiting

TTVR Early Feasibility Study

The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral a...

Birmingham, ALNA150 participantsMedtronic Cardiovascular

View Study Details

NCT06948214Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and vali...

Birmingham, ALPHASE3150 participantsLumos Pharma

View Study Details

NCT05764720Recruiting

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-re...

Birmingham, ALNA134 participantsVarian, a Siemens Healthineers Company

View Study Details

NCT05606432Recruiting

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise pro...

Birmingham, ALNA132 participantsUniversity of Alabama at Birmingham

View Study Details

NCT05336201Recruiting

Cognitive Remediation Intervention to Prepare for Transition of Care

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents...

Birmingham, ALPHASE2120 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06827990Recruiting

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections....

Birmingham, ALNA112 participantsW.L.Gore & Associates

View Study Details

NCT06829238Recruiting

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

This randomized clinical trial (RCT) evaluates whether metformin can reduce systemic inflammation and improve immune function in individuals with a history of injection drug use, with or without HIV. ...

Birmingham, ALPHASE4100 participantsUniversity of Alabama at Birmingham

View Study Details

NCT07221123Recruiting

Boosting Olfactory and Sensory Training Study (BOOST)

The goal of this study is to examine two types of olfactory interventions (conventional olfactory training vs scented marker training) in adults with HIV. The two research questions are: 1. Determin...

Birmingham, ALPHASE280 participantsUniversity of Alabama at Birmingham

View Study Details

NCT07031323Recruiting

OnTrackCF: Engagement, Feasibility, and Acceptability Study

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF)....

Birmingham, ALNA60 participantsBoston Children's Hospital

View Study Details

NCT06182072Recruiting

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

This is an open-label Phase I/Ib dose-escalation, dose-expansion clinical trial of the safety, pharmacokinetics and clinical activity of ProAgio combined with gemcitabine, nab-paclitaxel (G-nP) or gem...

Birmingham, ALPHASE146 participantsProDa BioTech, LLC

View Study Details

NCT06315257Recruiting

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients who have completed primary definitive therapy....

Birmingham, ALPHASE132 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT05193552Recruiting

Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease

Although there is evidence in the literature that gammaglobulin replacement therapy can lead to a reduction in the prevalence of pulmonary infection and improved lung function, there is no published s...

Birmingham, ALPHASE422 participantsUniversity of Alabama at Birmingham

View Study Details

NCT03587961Recruiting

Personalized Theratyping Trial

The purpose of this study is to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs....

Birmingham, ALEARLY_PHASE120 participantsGeorge Solomon

View Study Details

NCT07194044Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate th...

Birmingham, ALPHASE115 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Interstitial Cystitis Clinical Trials in Birmingham

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 38 interstitial cystitis clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 17,419 participants. Research is being sponsored by Stratpharma AG, St. Joseph's Hospital and Medical Center, Phoenix, Medical University of South Carolina and 28 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Birmingham — FAQ

Are there interstitial cystitis clinical trials in Birmingham?

Yes, there are 38 interstitial cystitis clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 38 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 17, 2026 from ClinicalTrials.gov